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Objectives: Pulmonary complication is a frequent morbid event after esophagec-
tomy for cancer. Its prediction may help select patients for preoperative
rehabilitation.
Methods: We performed a retrospective review of 292 patients (231 men and 61
women; mean age, 60.1 years) who underwent esophagectomy for cancer between
1980 and 2000. Data were analyzed to identify factors associated with the devel-
opment of pulmonary complications (reintubation for isolated respiratory failure and
pneumonia). A scoring system was developed, and its ability to predict complica-
tions was assessed.
Results: Resection was performed for squamous cancer (n  100), adenocarcinoma
(n  186), and other histologic types (n  6) in patients with stages 0 or I (n  53),
II (n 94), III (n 114), and IV (n 23) disease. Pulmonary complications, which
developed in 78 (27%) patients, were associated with a 4.5-fold increase in opera-
tive mortality (7%-32%). Multivariable analysis identified independent predictors of
pulmonary complications to be patient age (odds ratio [OR], 1.31; 95% confidence
interval [CI], 0.99-1.74; P .059), percentage forced expiratory volume in 1 second
(OR, 1.21; 95% CI, 1.07-1.38; P  .003), and possibly performance status (OR,
1.48; 95% CI, 0.88-2.50; P  .14). A scoring system using these 3 covariates was
developed, which predicted incremental risk of pulmonary complications (P 
.013). The incremental risks of cardiovascular and overall cardiopulmonary com-
plications were also predicted with this scoring system (P  .01 for each).
Conclusions: A scoring system using patient age, spirometry, and performance
status helps predict the likelihood of pulmonary and cardiovascular complications
after esophagectomy and can help select patients who may benefit from preoperative
cardiopulmonary rehabilitation.
Pulmonary complications such as pneumonia and respiratory insuffi-ciency are among the most frequent complications that develop afteresophagectomy. Their occurrence is associated with prolongation ofpostoperative hospital stay, increased cost of care, and substantialoperative mortality. Despite the recognition of this fact for more than2 decades, efforts at predicting the risk of pulmonary complications
have been only moderately successful. Alterations in intraoperative and postoper-
ative management of patients undergoing esophageal resection have failed to reduce
the incidence of pulmonary complications to desirable levels.
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We performed a review of patients undergoing esopha-
gectomy to determine the incidence of pulmonary compli-
cations and whether the incidence has changed over time.
We sought to identify risk factors associated with the de-
velopment of pulmonary complications to develop a scoring
system on the basis of preoperative parameters that would
permit the estimation of the likelihood of pulmonary com-
plications. The identification of factors that predict which
patients are at excess risk for pulmonary complications
might permit the development of methods for preventing
such complications through preoperative rehabilitation or
changes in operative techniques.
Patients and Methods
We performed a retrospective review of consecutive patients un-
dergoing esophagectomy for malignancy in the Thoracic Surgery
Service at The University of Chicago Medical Center from January
1980 through December 2000. Preoperative, operative, and post-
operative data were obtained from chart reviews for patients op-
erated on through 1989 and from a prospective database that was
initiated in 1990. Operations included either transthoracic or trans-
hiatal resections. Transthoracic approaches were used more often
during the early years of the period of review, and the frequency
of transhiatal resection increased during the latter portion of the
period of review (Figure 1). Postoperative complications were
categorized as pulmonary, cardiovascular, cardiopulmonary, sur-
gical, infectious, other complications, and death. Pulmonary com-
plications included the need for reintubation for isolated respira-
tory insufficiency postoperatively and pneumonia (fever, elevated
white blood cell count, and pulmonary infiltrate requiring antibi-
otic therapy). Cardiovascular complications included the need for
inotropic support to maintain blood pressure and perfusion (ex-
cluding the need for renal dose dopamine), arrhythmia, myocardial
infarction, and pulmonary embolism. Cardiopulmonary complica-
tions were any pulmonary or cardiovascular complication. Surgical
complications included anastomotic leak, necrosis of the recon-
structive organ, recurrent laryngeal nerve injury, and chylothorax.
Infectious complications consisted of empyema, intra-abdominal
abscess, and wound infection. Death was defined as mortality
during hospitalization for esophagectomy or within 30 days of
esophagectomy.
Data are expressed as means  SD. Continuous data were
analyzed with a 2-sided t test, and noncontinuous data were ana-
lyzed with 2 analysis. Variables that demonstrated an important
difference comparing patients without and with pulmonary com-
plications were examined with backwards stepwise multivariable
logistic regression analysis to identify important covariates pre-
dicting such complications. Important covariates were then com-
bined into a scoring system that was assessed for its utility in
predicting postoperative complications. Sensitivity, specificity,
and accuracy were calculated, and the utility of the scoring system
was evaluated by using receiver operating characteristic analy-
sis.1,2
Results
During the reference period, 292 patients underwent esoph-
agectomy for cancer. There were 231 men and 61 women,
with a mean age of 60.1  10.8 years (range, 30-84 years).
Demographic and other preoperative characteristics are
listed in Table 1. Baseline laboratory data and pulmonary
function data demonstrate that patients had relatively nor-
mal serum chemistries, blood counts, and pulmonary func-
tions (Table 2). Operations included exclusive left thoracot-
omy with intrathoracic anastomosis (n  83), left
thoracotomy with cervical anastomosis (n  33), right tho-
racotomy and laparotomy with intrathoracic anastomosis
(Ivor Lewis, n  21), right thoracotomy and laparotomy
with cervical anastomosis (n  73), transhiatal resection
with cervical anastomosis (n  74), and “other” (n  8,
Table 3). The majority of patients underwent reconstruction
with a gastric tube positioned in the bed of the resected
esophagus. Adenocarcinoma was the most common histo-
logic type and occurred in almost two thirds of patients.
Most patients had pathologic stage II or III disease. Overall
postoperative length of stay was 19  15 days (range, 0-82
days), which decreased during successive 5-year intervals
from 22.9  3.5 days during 1980 to 1984 to 14.1  2.0
days during 1996 to 2000 (P  .003).
Because a substantial proportion (21%) of patients did
not have pulmonary function tests performed preopera-
tively, the groups of patients with and without pulmonary
function tests were examined to determine whether there
were important differences between them. The only signif-
icant differences were that the patients who did not undergo
pulmonary function testing had lower serum albumin levels
(3.8  0.6 vs 4.0  0.4 mg/dL, P  .05), a lower incidence
of hypertension (21% vs 35%, P  .039), and a higher
incidence of preoperative radiotherapy (25.8% vs 10.0%,
P  .001). The incidence of pulmonary complications be-
Figure 1. The number of patients undergoing transthoracic resec-
tion (open bars) and transhiatal resection (filled bars) of esoph-
ageal cancer grouped by 2-year intervals. The numbers above the
columns indicate the percentages of patients undergoing trans-
hiatal resection during each interval.
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tween the 2 groups was similar (29.0% vs 26.1%, P  .6).
We concluded that the patients who underwent preoperative
pulmonary function testing were representative of the entire
population of patients undergoing resection.
Pulmonary complications occurred in 78 (26.7%) pa-
tients. These complications were associated with a signifi-
cant increase in postoperative length of stay, other nonfatal
postoperative complications, and operative mortality (Table
3). Pulmonary complications rarely occurred in the absence
of other complications, and isolated pulmonary complica-
tions were identified in only 6 (2.0%) patients. The inci-
dence of complications did not change significantly over the
time period of the study (Figure 2) and did not appear to
decrease, despite the increased use of transhiatal, rather than
transthoracic, resections (Table 3).
On the basis of the results of the univariate analysis,
variables selected as being potentially associated with pul-
monary complications were patient age, performance status
(Eastern Cooperative Oncology Group scale, assessed just
before the operation), percentage forced expiratory volume
in 1 second (FEV1%), body mass index (BMI) of less than
20 kg  m–2, diabetes mellitus, and a history of cigarette
smoking.3,4 Multivariable analysis (220 patients in the final
model) identified the important covariates to be patient age
(odds ratio [OR] of 1.31 for a 10-year increment; 95%
confidence interval [CI], 0.99-1.74; P .059), FEV1% (OR
of 1.21 for a 10-percentage point decrement; 95% CI, 1.07-
1.38; P  .003), and possibly performance status (OR of
1.48 for a 1-point increment; 95% CI, 0.88-2.50; P  .14).
These 3 covariates were combined into a scoring system
by assigning a point for each 10-year interval of age over 50
years (1 point for ages 51-60 years, 2 points for ages 61-70





complications (n  214)
Pulmonary complications
(n  78) P value
Men/women 292 231/61 173/41 58/20 .2
Age (y) 291 60.1 10.8 59.3 11.1 62.2 9.9 .035
Height (cm) 233 173.5 10.2 174.2 10.3 171.6 9.9 .07
Weight (kg) 260 75.5 24.5 75.8 16.7 70.9 17.9 .05
BMI (kg  m2) 229 24.8 4.8 25.1 4.5 24.2 5.6 .3
Weight loss (kg) 269 5.5 6.5 5.6 6.4 5.3 6.9 .7
Dysphagia 283 222 (78.4%) 159 (76.4%) 63 (84.0%) .17
Prior or current cigarette use 284 227 (79.9%) 160 (77.3%) 68 (88.3%) .038
Current alcohol use 281 208 (74.0%) 147 (71.7%) 61 (80.3%) .15
Diabetes mellitus 290 26 (9.0%) 14 (6.6%) 12 (15.4%) .02
Hypertension 291 94 (32.3%) 64 (30.0%) 30 (38.5%) .17
Preoperative chemotherapy 292 77 (26.4%) 58 (27.1%) 19 (24.4%) .6
Preoperative radiotherapy 292 39 (13.4%) 32 (15.0%) 7 (9.0%) .18
Prior MI 291 32 (11.0%) 22 (10.3%) 10 (12.8%) .5
Performance status 284 1.1 0.6 1.1 0.6 1.3 0.7 .004
MI, Myocardial infarction.





complications (n  214)
Pulmonary complications
(n  78) P value
Serum hemoglobin (g/dL) 279 13.1 2.0 13.1 1.9 13.0 2.1 .7
White blood cell count (1000/L) 275 7.3 3.0 7.3 3.2 7.5 2.5 .7
Serum albumin (mg/dL) 241 3.9 0.5 4.0 0.4 3.9 0.6 .6
Serum total protein (mg/dL) 231 6.9 0.6 6.9 0.6 7.0 0.7 .3
Serum creatinine (mg/dL) 273 1.1 0.4 1.1 0.4 1.1 0.3 .9
Serum total bilirubin (mg/dL) 239 0.6 0.3 0.6 0.3 0.6 0.3 .9
PO2 (mm Hg) 191 82.5 10.7 82.4 11.2 82.7 9.4 .8
PCO2 (mm Hg) 193 38.3 4.2 38.4 4.6 38.1 3.2 .5
FVC (L) 230 3.9 1.2 4.1 1.2 3.5 0.9 .003
FVC (%) 226 95.7 18.4 97.3 19.0 91.4 16.3 .024
FEV1 (L) 230 2.9 1.0 3.0 1.0 2.5 0.8 .003
FEV1 (%) 225 96.1 23.8 99.0 23.3 88.1 23.8 .003
FEV1/FVC (%) 230 72.4 10.5 73.1 10.1 70.5 11.5 .12
DLCO% 191 88.4 20.0 89.3 19.9 85.9 20.4 .3
FVC, Forced vital capacity; DLCO %, diffusing capacity for carbon monoxide expressed as a percentage of predicted and corrected for lung volume.
Ferguson and Durkin General Thoracic Surgery
The Journal of Thoracic and Cardiovascular Surgery ● Volume 123, Number 4 663
G
TS
years, 3 points for ages 71-80 years, and 4 points for age
80 years) and by assigning a point for each 10-percentage-
point interval of FEV1% under 90% (1 point for 80%-
89.9%, 2 points for 70%-79.9%, 3 points for 60%-69.9%,
and 4 points for values of 60%). These 2 values were
added to the performance status value to achieve a final
score (mean, 3.5  2.0) that had a nearly normal distribu-
tion (Figure 3). This score predicted an incrementally in-
creasing risk of complications (P  .013 for risk by score
category, Figure 4). The scores for patients without and with
pulmonary complications were 3.2  1.9 and 4.2  2.1,
respectively (P .003). Using a score of 4 as a cutoff value,
the accuracy of prediction of pulmonary complications was
65.4%.
This scoring system was evaluated for its ability to
predict other types of complications. Mean scores between
groups of patients with and without complications demon-
strated that, among cardiovascular, cardiopulmonary, infec-
tious, surgical, and other complications, significant differ-
ences in scores were found only for cardiovascular (3.1 
1.8 vs 4.1 2.2, P .001) and cardiopulmonary (3.0 1.8
vs 4.1  2.2, P  .001) complications. The relative risk of
cardiovascular and cardiopulmonary complications in-
creased with increasing scores (P  .005 and P  .001,
respectively; Figure 4). By using a score of 4 as a cutoff
value, the accuracy of this scoring system in predicting
cardiovascular and cardiopulmonary complications was
64.5% and 60.9%, respectively. The scores for patients with
and without any type of complication or nonfatal compli-
cation differed significantly, but this was due to the high
incidence of pulmonary and cardiovascular complications
among the affected patients. Mortality was not predicted by
the scoring system (3.4  2.0 vs 3.9  1.9, P  .2).
The decision threshold characteristics of the scoring sys-
tem for pulmonary, cardiovascular, and cardiopulmonary
complications were examined by using receiver operating
characteristic analysis (Figure 5). Although all curves ex-
hibit a good fit relative to the data points, this is largely a
function of the small number of decision thresholds avail-
able in the scoring system. The relatively small deviation of
the curves from the line of unity (representing no discrim-
ination) suggests that the scoring system is good but not
optimal as a means for predicting the likelihood of these
complications.
Because pulmonary function test results are an important
element in the scoring system, an examination of preoper-
ative variables was undertaken to determine whether the
risk of poor pulmonary function test results could be deter-
mined. Univariate analyses identified possible covariates to
be sex, amount of weight loss, current or past cigarette use,




complications (n  214)
Pulmonary complications
(n  78) P value
Any thoracotomy 284 210 (73.9%) 149 (72.0%) 61 (79.2%) .2
Any laparotomy 284 168 (59.2%) 116 (56.0%) 52 (67.5%) .08
Thoracotomy and laparotomy 284 94 (33.1%) 58 (28.0%) 36 (46.8%) .003
Transhiatal resection 287 74 (25.8%) 58 (27.6%) 16 (20.8%) .2
Transthoracic resection only 287 116 (40.4%) 91 (43.3%) 25 (32.5%) .1
Substernal reconstruction 285 8 (2.8%) 2 (1.0%) 6 (7.8%) .002
EBL (mL) 272 1208 1262 1168 1332 1320 1042 .3
Transfusion (units) 265 2.7 3.8 2.5 3.9 3.4 3.8 .07
Histology 290 .001*
Squamous cell 100 (34.5%) 61 (28.8%) 39 (50.0%)
Adenocarcinoma 186 (64.1%) 147 (69.4%) 39 (50.0%)
Other 4 (1.4%) 4 (1.9%) 0 (0%)
Stage 286 .16
0,I 53 (18.5%) 42 (20.1%) 11 (14.3%)
II 94 (32.9%) 66 (31.6%) 28 (36.4%)
III 115 (40.2%) 80 (38.3%) 35 (45.5%)
IV 24 (8.4%) 21 (10.0%) 3 (3.9%)
LOS (d) 291 19.0 15.0 13.9 9.6 32.9 18.1 .001
Complications
Cardiovascular 292 106 (36.3%) 51 (23.8%) 55 (70.5%) .001
Infectious 292 55 (18.8%) 25 (11.7%) 30 (38.5%) .001
Surgical 292 76 (26.0%) 45 (21.0%) 31 (39.7%) .001
Other 292 105 (36.0%) 59 (27.6%) 46 (59.0%) .001
Overall nonfatal 292 160 (54.8%) 107 (50.0%) 53 (68.0%) .006
Mortality 292 40 (13.7%) 15 (7.0%) 25 (32.1%) .001
EBL, Estimated blood loss; LOS, length of postoperative hospital stay.
*Comparing squamous cell and adenocarcinoma histologies only.
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alcohol consumption, BMI of less than 20 kg  m–2, hyper-
tension, serum creatinine level, and performance status.
Backwards stepwise multivariable logistic regression anal-
ysis identified the significant covariates for FEV1% of less
than 90% to be weight loss (OR for a 2-kg decrement, 1.03;
95% CI, 1.00-1.05; P  .034), alcohol use (OR, 3.92; 95%
CI, 1.58-9.69; P  .003), and BMI of less than 20 kg  m–2
(OR, 8.36; 95% CI, 2.54-27.51; P  .001).
The role of the operative approach in the development of
postoperative pulmonary complications was evident on the
basis of the large influence of combined thoracotomy and
laparotomy. This technique was significantly more likely to
be associated with such complications than was either an
exclusive transthoracic approach or a transhiatal approach
(P  .012). When combined thoracotomy and laparotomy
as the operative approach was added as a variable in the
multivariable analysis of factors associated with pulmonary
complications, the important covariates that emerged were
FEV1% (10-percentage-point decrement: OR, 1.20; 95% CI,
1.05-1.37; P  .006), operative approach (OR, 2.49; 95%
Figure 2. The number of patients without (open bars) and with
(filled bars) pulmonary complications after esophagectomy for
cancer grouped by 2-year intervals. The numbers above the
columns are the percentages of patients who had postoperative
pulmonary complications during each interval.
Figure 3. Distribution of risk scores for pulmonary complica-
tions.
Figure 4. The incidence of pulmonary (P  .013), cardiovascular
(P  .005), and cardiopulmonary (P  .001) complications in
relation to the predictive score.
Figure 5. Receiver operating characteristic curves for the scoring
system relative to pulmonary complications (circles, r 2  0.99),
cardiovascular (triangles, r 2  0.99), and cardiopulmonary com-
plications (inverted triangles, r 2  0.99). The line of unity (no
discrimination) is depicted as a dashed line.
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CI, 1.30-4.76; P  .006), and age (10-year increment: OR,
1.34; 95% CI, 0.99-1.81; P  .06).
Discussion
The risk of pulmonary complications after esophagectomy
is higher than after any other common operation, including
major lung resection. The reasons posited for this high risk
include surgical entry into 2 separate body cavities; disrup-
tion of bronchial innervation and lymphatic circulation;
postoperative dysfunction of muscles of respiration, includ-
ing the diaphragm; placement of a reconstructive organ in
the substernal space; cachexia; advanced age; poor airway
protection resulting from recurrent laryngeal nerve injury and
discoordinated deglutition; tobacco and alcohol abuse; and
poor performance status. The high incidence of pulmonary
complications after esophagectomy has been recognized for
decades, and a variety of intraoperative and postoperative
techniques have been used in attempts to reduce the frequency
of this problem. Unfortunately, the potential salutary effects
of these interventions have not been fully realized. Al-
though incentive spirometry, intermittent positive-pressure
breathing, and chest physiotherapy substantially reduce the
incidence of pulmonary complications after major abdomi-
nal surgery, similar efforts combined with more careful
patient selection have succeeded in reducing the incidence
of pulmonary complications after esophagectomy in rela-
tively few institutions.5-8
The incidence of pulmonary complications was rela-
tively stable in our institution over 2 decades, despite the
introduction of routine postoperative epidural analgesia, a
growing emphasis on early extubation, the increasingly
vigorous use of pulmonary toilet exercises, and a more
frequent use of the transhiatal approach for resection. The
incidence of pulmonary complications we identified is
within the 20% to 35% range reported by others.9-16 Direct
comparisons between reports are sometimes difficult be-
cause of the differing definitions of what a pulmonary
complication is and the natural attrition in the number of
complications identified through retrospective, rather than
prospective, studies. In addition, the substantial overlap
between organ system complications suggests that identify-
ing true pulmonary complications is often an inexact sci-
ence.
Attempts to develop systems for predicting which pa-
tients are at increased risk of development of pulmonary
complications have been only partially successful. In addi-
tion, many studies identify factors (intraoperative blood
loss, use of epidural analgesia, use of bronchoscopy post-
operative to clear secretions, tumor stage, and duration of
the operation) that cannot be used to preoperatively predict
the risk of complications.8,11,17 As a result, their focus is on
identifying which patients should experience altered opera-
tive and postoperative management, and in most instances
they do not address the potential for preoperative interven-
tion in limiting pulmonary complications.
The relative lack of utility of other perioperative predic-
tive systems and the absence of adequate benefit provided
by changes in operative and postoperative management
have led to the concept of identification of and intervention
for high-risk patients in the preoperative period. We iden-
tified 3 preoperative factors that were associated with an
increased risk of pulmonary complications: age, spirometric
values, and performance status. Others have demonstrated
that advanced age and preoperative respiratory dysfunction
are associated with postoperative pulmonary complica-
tions.11,12,14,17 It may be intuitively apparent that the factors
we identified are predictive of the relative risk of develop-
ment of pulmonary complications. The benefit of this anal-
ysis does not lie in the uniqueness of our observations.
Instead, it directs the clinician to focus on a few specific
factors and provides the ability to quantitate the relative
effect of these factors before making treatment recommen-
dations.
Age, spirometry, and performance status have several
advantages in their use in a preoperative system for predict-
ing postoperative complications. Age and spirometry are
objective measurements, and performance status is based on
a method of clinical observation that has been validated
during 2 decades of use.18-20 Only a brief patient interview
and a single test, which can be performed in a physician’s
office, are necessary to enable the clinician to compile the
required information. Combining these factors into a scor-
ing system permits the assessment of relative risk on the
basis of all 3 factors simultaneously. The intent of devel-
oping such a scoring system is so that preoperative inter-
ventions can be recommended that may reduce the risk of
postoperative complications. That this is a potentially effec-
tive approach is evidenced by significant improvements
demonstrated in patients who undergo a short period of
cardiopulmonary rehabilitation in preparation for lung re-
section for cancer or lung volume reduction surgery for
severe emphysema.21,22 Whether the risk of postoperative
pulmonary complications can be reduced in patients under-
going esophagectomy by means of improving respiratory
muscle strength and performance status has yet to be inves-
tigated.
A good predictive scoring system should be easy to use,
have low cost, require little or no special testing, be a good
predictor of outcomes for a given population, be a good
predictor of outcome for an individual, provide meaningful
results that guide clinical behavior, and either provide a
specific value that separates low-risk from high-risk groups
or provide a continuous incremental estimate of risk. Our
scoring system fulfills many of these criteria. It is easy to
use: To calculate a risk score, no complex formulas or
transformations are necessary, and the score can be calcu-
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lated in one’s head. The cost is low because only one
clinical test is required, and this is often obtained routinely.
The system provides an incremental estimate of risk with
which outcomes for a population can be predicted. It also
uses 2 factors that can potentially be modified to reduce risk
once it is identified. However, the system does not have the
power to accurately predict outcome for an individual, and
there is no specific cutoff value that clearly demarcates
standard-risk and high-risk populations.
There are limitations to the use of this algorithm. It is
unclear whether a demonstrated improvement in spirometry
is necessary to confer benefits on patients. The time neces-
sary to produce measurable improvement in performance is
unknown and may differ among patients. Any delay in
resection or other therapy mandated by the need for preop-
erative cardiopulmonary rehabilitation may permit tumor
growth, resulting in increased symptoms and decreasing
performance status. It is unclear as to how neoadjuvant
chemotherapy, radiotherapy, or both affect performance sta-
tus and spirometry and whether such interventions have any
effect on the scoring system and its potential utility.
Although many surgeons obtain preoperative pulmonary
function tests routinely on their patients undergoing esoph-
agectomy, there is no standard clinical practice in this
regard. Thus, it would be helpful to the clinician to know
which patients should be sent for pulmonary function test-
ing. The accuracy of predicting poor pulmonary function
with any available algorithm other than clinical acumen is
low. However, some guidance is available from our analy-
ses, which demonstrate that the combination of alcohol use,
excessive weight loss, and, most important, a BMI of less
than 20 kg  m–2 should alert the clinician to the possibility
of a greater than average risk of poor pulmonary function.
We also analyzed the effect of the operative approach on
the development of pulmonary complications postopera-
tively. The combination of a thoracotomy and a laparotomy,
such as is used in performing an Ivor Lewis esophagectomy,
was highly predictive of the development of such compli-
cations. The effect of thoracoabdominal incisions on post-
operative complications was not assessed because of the
small number of such operations in our database, but it is
likely that such an approach would have a similar negative
effect on the incidence of pulmonary complications. In light
of this finding, it is interesting to speculate about how
alterations in the operative approach, including the use of
minimally invasive surgical procedures, might diminish the
incidence of postoperative pulmonary complications. Given
the inherent bias engendered by the surgeon’s selection of
operative approaches on the basis of preoperative assess-
ment of patients, it is not possible to formulate an algorithm
that would assist in decisions about the optimal surgical
approach for an individual patient.
Pulmonary complications remain among the most com-
mon problems that confront the esophageal surgeon. Cur-
rent efforts to minimize these complications have not been
completely successful. A new scoring system identifies pop-
ulations at excess risk for pulmonary complications and
may permit preoperative intervention, which reduces the
risk of such problems. However, before its use can be
recommended, this system requires validation through ret-
rospective analyses of data from other centers and through
prospective clinical trials.
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Discussion
Dr Richard I. Whyte (Stanford, Calif). A close look at the data
suggests that if you have one of these complications there is a
4-fold higher incidence of death, so I wonder why it predicts one
but not the other.
I have 2 questions. First of all, your preoperative data set did
not appear to include the year of the operation. If you include the
year of the operation, do you see a significant change in the patient
population as time goes on? In other words, are you now operating
on older, sicker patients?
The second question relates to the use of preoperative chemo-
therapy and radiation. I think a number of us who have used
preoperative chemotherapy and radiation in patients undergoing
esophagectomy have seen an incidence of people with an early
postoperative adult respiratory distress syndrome–like pattern that
can significantly complicate their postoperative hospitalization and
even result in mortality. You did not identify patients in your series
that had preoperative chemotherapy and radiation. Do you think
this also is a risk factor?
Dr Ferguson. Thank you for your kind comments. I agree that
it is obvious to most that these types of factors would likely predict
the risk of pulmonary complications. I think the potential advan-
tage in what we have identified is the ability to quantitate the
individual risk for these patients.
Our series is not different than most in finding that there has
been no difference in the incidence of pulmonary complications
over time. In fact, only 2 reports in the literature have identified a
reduction in pulmonary complications in the last decade or so:
Wong’s group from Hong Kong and Heitmiller’s group from
Hopkins. In fact, most of the studies comparing transthoracic with
transhiatal resection have also shown no difference in the inci-
dence of pulmonary complications, so it is not surprising that the
increased use of this technique has not resulted in a decrease in the
number of complications.
You asked whether there has been a change in the patient
population on the basis of age, other risk factors, or perhaps the use
of preoperative chemotherapy and radiation therapy. We could
identify no change in the patients that we have operated on over
this roughly 2-decade period. We looked specifically at preopera-
tive chemotherapy and radiation therapy and found that they were
not even close to being predictors for the likelihood of complica-
tions, so I think, intuitively, that once again this is a potential risk
factor but does not bear out in the statistical analysis.
We also did look at the year of operation as a confounding
variable, and this did not create any significant difference in the
population, so it did not enter into the multivariable analysis.
Dr Alden Harken (Denver, Colo). This is a thoughtful review
of a complex and very high-risk group of patients. I was struck, as
you were, by the link between the cardiac and the pulmonary
complications, and I think we have all seen that once the first
domino goes down, they all spiral.
I was interested that your cardiac complications were greater
than your pulmonary complications: 36% versus 27%. I was struck
that, for the past 15 years, we have all recognized that patients
around a myocardial infarction on -blockers do much better.
Poulderman’s multi-institutional review in the New England Jour-
nal of Medicine 2 years ago took very high-risk vascular patients
and, by placing them on -blockers, was able to cut down the
cardiac complications in this dobutamine stress echocardiography
high-risk vascular surgical group from 34% down to 3.4% with
-blockers alone. Do you use -blockers, or have you looked at
this group as to whether they were on -blockers? There is
progressively persuasive evidence that noncardiac surgical patients
probably should be on—or at least the moderate and high-risk
surgical groups should be on—-blockers. Is the cardiovascular
advantage of -blockers offset by the bronchospastic disadvantage
of -blockers? What would be your recommendations in this
group for the use of what appears to be a rational preventive
perioperative cardiovascular risk program? Have you looked at
perioperative -blockers, and what would be your recommenda-
tion for the future?
Dr Ferguson. Thank you. It is an interesting problem. I do not
know that it has been specifically studied in patients undergoing
esophagectomy with regard to the relative risk of pulmonary
versus cardiovascular complications. It all depends on definition.
In fact, we excluded a number of patients who most would con-
sider as having pulmonary complications, requiring reintubation
for respiratory failure, because we believe the respiratory failure
was associated with other problems, such as sepsis and massive
myocardial infarction. We did not exclude patients in the cardio-
vascular risk group, and so that is why it may appear somewhat
artificially higher than that in the pulmonary complication group.
The vast majority of the complications in the cardiovascular group
were relatively benign. We had few that affected mortality—
maybe 6 myocardial infarctions, I think 2 or 3 pulmonary emboli,
very few patients requiring inotropic support for something other
than sepsis—and so almost all those patients had arrhythmias that
are relatively benign. One could consider the use of -blockers,
particularly the more selective blockers, but I am still quite con-
cerned about the risk of increasing pulmonary complications in
these patients. We do not have data on it, so I have not been able
to specifically look at the potential benefit of -blockers in this
patient population.
Dr Douglas E. Wood (Seattle, Wash). I have a couple of
questions for you. One question relates to the second analysis that
you did on the type of operative approach and its effect on
complications. I guess I would like to rechallenge you on what you
think the validity of that analysis is. You are presumably compar-
ing very different patient populations—a group of patients that
have bulky squamous carcinomas of the midesophagus, potentially
of a different tumor stage group as well—from those I am pre-
suming to have gastroesophageal-junction tumors with or without
Barrett esophagus. Do you think it is fair to ignore those factors
that led to your selection of an approach, which may be the most
important component of determining complications?
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Second, you propose that the reason for doing this is to identify
a high-risk group of patients that could potentially benefit from
pulmonary rehabilitation. Do we have time to do pulmonary reha-
bilitation in patients that have esophageal cancer? Pulmonary
rehabilitation programs are generally 6 weeks to 3 months. These
patients may be getting induction therapy and may have difficulty
doing pulmonary rehabilitation during that, or they may have
issues that prevent them from being able to wait that period of time
before having a definitive procedure. Is it really going to help?
Dr Ferguson. Time prevented my discussing most of these
issues during the talk, but you are right. There are certain issues
with the approach to the operation that are very specific and may
have also influenced the outcome in these patients. I do not know
that there is a good way to sort it out, so I would caution accepting
that finding without looking further into it. On the other hand, it
still indicates the potential for a different operative approach, such
as a minimally invasive resection. This could accomplish the same
resection as the 3-hole esophagectomy if our techniques improve
and thus has the potential for limiting complications without
compromising the approach to the operation.
With regard to rehabilitation, yes, there are certain disadvan-
tages. One is that the performance status of the patient could
actually worsen because of worsening dysphagia. It may interrupt
preoperative chemotherapy and radiation therapy. It may provide
too long of an interval between the radiation and the operation.
Those are all potential disadvantages. On the other hand, some
benefit has been seen in patients who got even a minimum of 2
weeks of fairly intensive cardiopulmonary rehabilitation, so I think
something like that could still be considered in the majority of
these patients who are thought to be at high risk.
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